- Home
- CELC vs DDI Comparison
CELC vs DDI Comparison
Compare CELC & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- DDI
- Stock Information
- Founded
- CELC 2011
- DDI 2008
- Country
- CELC United States
- DDI South Korea
- Employees
- CELC N/A
- DDI N/A
- Industry
- CELC Medical Specialities
- DDI EDP Services
- Sector
- CELC Health Care
- DDI Technology
- Exchange
- CELC Nasdaq
- DDI Nasdaq
- Market Cap
- CELC 440.0M
- DDI 472.2M
- IPO Year
- CELC 2017
- DDI 2021
- Fundamental
- Price
- CELC $57.43
- DDI $9.31
- Analyst Decision
- CELC Strong Buy
- DDI Strong Buy
- Analyst Count
- CELC 5
- DDI 5
- Target Price
- CELC $53.60
- DDI $19.60
- AVG Volume (30 Days)
- CELC 906.9K
- DDI 48.9K
- Earning Date
- CELC 08-14-2025
- DDI 11-10-2025
- Dividend Yield
- CELC N/A
- DDI N/A
- EPS Growth
- CELC N/A
- DDI N/A
- EPS
- CELC N/A
- DDI 2.15
- Revenue
- CELC N/A
- DDI $333,256,000.00
- Revenue This Year
- CELC N/A
- DDI $14.45
- Revenue Next Year
- CELC N/A
- DDI $5.69
- P/E Ratio
- CELC N/A
- DDI $4.38
- Revenue Growth
- CELC N/A
- DDI 0.24
- 52 Week Low
- CELC $7.58
- DDI $8.09
- 52 Week High
- CELC $63.06
- DDI $18.21
- Technical
- Relative Strength Index (RSI)
- CELC 64.38
- DDI 41.62
- Support Level
- CELC $50.44
- DDI $9.37
- Resistance Level
- CELC $63.06
- DDI $9.74
- Average True Range (ATR)
- CELC 3.17
- DDI 0.25
- MACD
- CELC -0.47
- DDI -0.01
- Stochastic Oscillator
- CELC 60.71
- DDI 16.16
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.